Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Amtagvi’s approval introduces a novel approach in the treatment of advanced melanoma, employing patient-derived TIL-cell therapy to target tumors with precision, offering a beacon of hope for those with limited options.
Dermatology March 4th 2024
The Epoch Times
Equip yourself with comprehensive knowledge about skin cancer to better educate your patients. Learn more about its types, symptoms, risk factors, diagnosis methods, treatments, stages, complications, and prevention strategies.
Dermatology October 23rd 2023
OBR Oncology
Learn how Olivia Kerins leverages her roles in healthcare and sports to fuel her passion for community service and education—offering a unique model for broad impact.
Nursing September 25th 2023
Explore the latest research from McGill University that uncovers the demographic factors influencing melanoma risk, offering actionable insights for targeted prevention strategies.
Dermatology August 28th 2023
Medical Professionals Reference (MPR)
A 77-year-old man with a history of solar keratoses presents a progressively enlarging and darkening lesion on his right cheek, as observed by his wife over a year, with a dermoscopic examination revealing asymmetric pigmented follicular openings and greyish globules and dots.
Dermatology July 20th 2023
Practical Dermatology
Curettage and cryosurgery is a safe and effective treatment method for basal cell carcinoma. The method is well tolerated by patients and has a low recurrence rate.
Dermatology July 12th 2023